Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Effect of inhaled corticosteroid particle size on asthma efficacy and safety outcomes: a systematic literature review and meta-analysis

Fig. 3

Benefit-risk plot in adolescents and adults by particle size. AM, morning; BDP, beclometasone dipropionate; CI, confidence interval; CIC, ciclesonide; CO, crossover; FEV1, forced expiratory volume in 1 s; FEF25–75%, % predicted forced expiratory flow between 25% and 75% of forced vital capacity; FP, fluticasone propionate; FP/SAL, fluticasone propionate/salmeterol; hCRF, human corticotropin-releasing factor; PEF, peak expiratory flow; PM, evening

Back to article page